MORE. Not a word you’d expect to associate with myeloma, is it? Actually, it may the perfect word for looking beyond this rare, incurable, AND treatab…
This study is designed to speed up the approval of acute myeloid leukemia (AML) drugs and bring safe and effective treatments to pediatric patients.
Shock. Grief. Needing support from your community. Costs of medication, doctors’ appointments, treatment. These are all common with a blood ca…
_dam_file_163661.jpg?crop=true&keep=c&w=400&h=400)
When I meet blood cancer survivors and their families, they often share their personal stories with me. Sometimes they talk about the relief of findin…
The Leukemia & Lymphoma Society (LLS) is proud of our continuing partnership with Gilead and Kite Oncology as the National Presenting Sponsor of Celeb…
Sunday marked a significant milestone for The Leukemia & Lymphoma Society (LLS) and the patients we help. Here at the 60th American Society of Hematol…
The Leukemia & Lymphoma Society is dedicated to helping find cures for pediatric blood cancers. But we—and pediatric families across the country—know …
When you commit time and talent to a nonprofit’s mission – no matter how you choose to get involved – you become a volunteer, and the impact of your e…
A complete blood count (CBC), blood smear, and urinalysis can help doctors diagnose leukemia, lymphoma, myeloma, and other types of blood cancers.
Support Resources
A complete blood count (CBC), blood smear, and urinalysis can help doctors diagnose leukemia, lymphoma, myeloma, and other types of blood cancers.
Support Resources
A complete blood count (CBC), blood smear, and urinalysis can help doctors diagnose leukemia, lymphoma, myeloma, and other types of blood cancers.
Support Resources
Many blood cancer survivors remember the day they were diagnosed, and they never forget it. For Racheli Alkobey Peltier—Director of Diversity, Equity,…
WATERTOWN, Mass., June 09, 2023 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degr…
LLS’s Investment in Leading-Edge Research Aims to Accelerate Treatment Innovation and Expand Equitable Access to Treatments to Increase the Quality of…
More than 25,000 medical professionals from across the world came together in December to discuss the latest blood cancer developments during the annu…
When we think about the future, a lot can feel uncertain—especially as a teenager or young adult (AYA) with blood cancer. We get it. The AYA crowd f…
Too many parents lose their children to blood cancer each year. It’s a devastating experience for families blindsided by the harsh realities of cancer…
I was always aware that volunteers with The Leukemia & Lymphoma Society (LLS) drive impact for blood cancer patients and families. But it wasn’t until…
SAN DIEGO, May 20, 2021 - BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving cancer medicines, today announ…
Dr. Will has been a group leader at the Albert Einstein College of Medicine since 2016. She obtained her Ph.D. in Cell Biology from the University of …
Dr. Collins is a postdoctoral fellow in Dr. Ravi Majeti’s lab at Stanford University and a senior clinical fellow in the Hematology and Oncology Depar…
We want to understand how leukemia inhibits blood production as this is one of the main causes of death in leukemia patients. We use new microscopy te…
JR Miller at Palomani Pass, the highest point on the Ausangate trek in Peru at 5,200 meters (17,060 feet)After 25 years of service to The Leukemia & L…
T-cell lymphomas comprise approximately 10-15% of all Non-Hodgkin’s Lymphomas (NHLs). The main subsets are peripheral T-cell lymphoma (PTCL) and cutan…
Research: Grants
Research: TAP
In honor of Blood Cancer Awareness Month, Dr. Gwen Nichols reflects on our vital work to support blood cancer patients and their families.
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.